CXCR4-directed theranostics in oncology and inflammation Malte KircherPeter HerhausConstantin Lapa Invited Review Article Open access 13 August 2018 Pages: 503 - 511
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications Rudolf A. WernerRalph A. BundschuhSteven P. Rowe Review Article Open access 14 August 2018 Pages: 512 - 522
Reproducibility of standardized uptake values of same-day randomized 68Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients Anna RingheimGuilherme de Carvalho Campos NetoRonaldo Hueb Baroni Original Article 07 July 2018 Pages: 523 - 531
Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma Domenico AlbanoMattia BertoliFrancesco Bertagna Original Article 07 July 2018 Pages: 532 - 541
Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer Halil KomekCanan CanSerdar Altindag Original Article 13 July 2018 Pages: 542 - 552
Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial Michael J. SeiderStephanie L. Pughfor the NRG Oncology Original Article 09 August 2018 Pages: 553 - 560
Detectability of residual invasive bladder cancer in delayed 18F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling Akira HigashiyamaTsuyoshi KomoriYoshifumi Narumi Original Article 16 July 2018 Pages: 561 - 567
Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate Roberto A. Escala CornejoPaloma García-TalaveraJuan J. Cruz Hernández Report 26 July 2018 Pages: 568 - 572
Diagnosing polymyalgia rheumatica on 18F-FDG PET/CT: typical uptake patterns Shunsuke YugeKoya NakataniTakashi Koyama Short Communication 08 June 2018 Pages: 573 - 577